Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)
- 1 September 1999
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 5 (9), 540-546
- https://doi.org/10.1111/j.1469-0691.1999.tb00432.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Bacterial Topoisomerases, Anti‐Topoisomerases, and Anti‐Topoisomerase ResistanceClinical Infectious Diseases, 1998
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- The emergent needs for basic research, education, and surveillance of antimicrobial resistance: Problems facing the report from the American Society for Microbiology task force on antibiotic resistanceDiagnostic Microbiology and Infectious Disease, 1996
- Emerging Resistance to Antimicrobial Agents in Gram-Positive BacteriaDrugs, 1996
- Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humansAntimicrobial Agents and Chemotherapy, 1995
- Erratum to: Levofloxacin: a review of its antibacterial activity, pharmacokinetics and therapeutic efficacyDrugs, 1994
- LevofloxacinDrugs, 1994
- In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinoloneAntimicrobial Agents and Chemotherapy, 1994
- In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneAntimicrobial Agents and Chemotherapy, 1993
- In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinoloneAntimicrobial Agents and Chemotherapy, 1992